Pacific Biosciences of Ca... (PACB)
1.31
-0.14 (-9.66%)
At close: Mar 03, 2025, 3:59 PM
1.37
4.18%
Pre-market: Mar 04, 2025, 06:48 AM EST
Pacific Biosciences of California Income Statement
| Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | FY09 | FY08 | FY07 |
| Revenue | 154.01M | 200.52M | 128.3M | 130.51M | 78.89M | 90.89M | 78.63M | 93.47M | 90.71M | 92.78M | 60.59M | 28.18M | 25.98M | 33.86M | 1.67M | 135K | 901K | 2.16M |
| Cost of Revenue | 116.73M | 147.74M | 79.27M | 71.65M | 46.33M | 56.31M | 53.53M | 58.81M | 46.55M | 39.33M | 37.19M | 21.76M | 25.04M | 20.83M | n/a | n/a | n/a | n/a |
| Gross Profit | 37.28M | 52.78M | 49.03M | 58.86M | 32.57M | 34.58M | 25.1M | 34.66M | 44.16M | 53.45M | 23.4M | 6.42M | 940K | 13.03M | 1.67M | 135K | 901K | 2.16M |
| Operating Income | -356.38M | -334.47M | -304.82M | -178.16M | -104.39M | -100.55M | -100.99M | -89.78M | -71.24M | -29.13M | -62.85M | -77.54M | -94.34M | -109.76M | -140.23M | -88.07M | -44.81M | -23.39M |
| Interest Income | n/a | n/a | 14.69M | 12.53M | 267K | 2.61M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 172K | 451K | 1.16M | 1.94M |
| Pretax Income | -308.33M | -318.16M | -314.25M | -274.87M | 29.4M | -84.13M | -102.56M | -92.19M | -74.38M | -31.7M | -66.16M | -79.29M | -94.47M | -109.39M | -140.17M | -87.7M | -43.75M | -21.52M |
| Net Income | -308.65M | -306.74M | -296.93M | -181.22M | 29.4M | -77.82M | -102.56M | -92.19M | -74.38M | -31.7M | -66.16M | -79.29M | -94.47M | -109.39M | -140.17M | -87.7M | -43.75M | -21.52M |
| Selling & General & Admin | 175.02M | 169.82M | 160.85M | 124.12M | 72.8M | 75.49M | 63.49M | 59.12M | 47.79M | 45.19M | 38.03M | 38.74M | 47.66M | 46.71M | 30.09M | 12.33M | 7.71M | 6.34M |
| Research & Development | 134.92M | 187.17M | 193M | 112.9M | 64.15M | 59.63M | 62.59M | 65.32M | 67.62M | 60.44M | 48.23M | 45.22M | 47.62M | 76.08M | 111.82M | 75.88M | 38M | 19.22M |
| Other Expenses | 83.72M | 30.26M | 7.64M | 93K | 2.06M | 1.02M | 848K | 516K | 103K | 364K | -478K | 728K | -127K | n/a | -104K | -84K | -102K | -67K |
| Operating Expenses | 393.66M | 387.25M | 353.85M | 237.02M | 136.95M | 135.12M | 126.08M | 124.44M | 115.4M | 105.63M | 86.26M | 83.96M | 95.28M | 122.79M | 141.91M | 88.2M | 45.71M | 25.55M |
| Interest Expense | -13.41M | 14.34M | 14.69M | 12.53M | 267K | 2.61M | 2.42M | 2.92M | 3.23M | 2.93M | 2.83M | 2.48M | n/a | 287K | n/a | n/a | n/a | n/a |
| Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Cost & Expenses | 510.39M | 534.99M | 433.12M | 308.68M | 183.28M | 191.44M | 179.61M | 183.25M | 161.96M | 144.96M | 123.45M | 105.72M | 120.32M | 143.62M | 141.91M | 88.2M | 45.71M | 25.55M |
| Income Tax | 316K | -11.42M | -17.32M | -93.65M | -6.98M | -6.32M | 848K | -5M | 3.34M | -387K | 2.35M | 3.21M | n/a | -368K | -172K | -451K | -1.16M | -1.94M |
| Shares Outstanding (Basic) | 274.49M | 253.63M | 224.46M | 203.62M | 172.96M | 152.53M | 134.95M | 105.68M | 89.15M | 75.61M | 70.47M | 62.78M | 55.73M | 53.87M | 9.94M | 773.84K | 773.84K | 27.74M |
| Shares Outstanding (Diluted) | 288.37M | 253.63M | 224.55M | 204.14M | 174.97M | 152.53M | 135.09M | 105.68M | 89.15M | 75.61M | 70.47M | 62.78M | 55.73M | 53.87M | 9.94M | 773.84K | 773.84K | 27.74M |
| EPS (Basic) | -1.12 | -1.21 | -1.32 | -0.89 | 0.18 | -0.51 | -0.76 | -0.87 | -0.83 | -0.42 | -0.94 | -1.26 | -1.69 | -2.03 | -14.1 | -113.33 | -56.54 | -0.78 |
| EPS (Diluted) | -1.07 | -1.21 | -1.32 | -0.89 | 0.17 | -0.51 | -0.76 | -0.87 | -0.83 | -0.42 | -0.94 | -1.26 | -1.69 | -2.03 | -14.1 | -113.33 | -56.54 | -0.78 |
| EBITDA | -356.38M | -277.28M | -282.24M | -250.76M | 38.97M | -71.58M | -92.92M | -80.83M | -67.27M | -25.09M | -59.11M | -71.17M | -87.52M | -103.28M | -135.01M | -83.97M | -41.82M | -21.81M |
| Depreciation & Amortization | n/a | 26.53M | 17.32M | 11.59M | 9.3M | 9.95M | 7.21M | 8.44M | 3.88M | 3.68M | 4.22M | 5.65M | 6.65M | 5.8M | 5.16M | 4.1M | 2.99M | 1.58M |